bnt162b2 xbb.1.5 Search Results


bnt162b2 xbb.1.5  (BioNTech)
90
BioNTech bnt162b2 xbb.1.5
Bnt162b2 Xbb.1.5, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 xbb.1.5/product/BioNTech
Average 90 stars, based on 1 article reviews
bnt162b2 xbb.1.5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bnt162b2 xbb.1.5adapted vaccine  (Pfizer Inc)
90
Pfizer Inc bnt162b2 xbb.1.5adapted vaccine
Bnt162b2 Xbb.1.5adapted Vaccine, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 xbb.1.5adapted vaccine/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
bnt162b2 xbb.1.5adapted vaccine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bnt162b2 omi xbb.1.5  (Pfizer Inc)
90
Pfizer Inc bnt162b2 omi xbb.1.5
Representative completed and ongoing clinical studies (immunotherapy)
Bnt162b2 Omi Xbb.1.5, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 omi xbb.1.5/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
bnt162b2 omi xbb.1.5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Representative completed and ongoing clinical studies (immunotherapy)

Journal: Signal Transduction and Targeted Therapy

Article Title: Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

doi: 10.1038/s41392-024-02002-z

Figure Lengend Snippet: Representative completed and ongoing clinical studies (immunotherapy)

Article Snippet: BNT162b2 (Omi XBB.1.5) + RIV , COVID-19 and influenza , 2024-01-31 , Phase II , Active, not recruiting , Pfizer , NCT06237049.

Techniques: Virus, Injection, Membrane, Immunopeptidomics, Adjuvant, Activity Assay, Plasmid Preparation, Saline, Electroporation, Transfection, Inhibition

Clinical trials were conducted according to different age groups

Journal: Signal Transduction and Targeted Therapy

Article Title: Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

doi: 10.1038/s41392-024-02002-z

Figure Lengend Snippet: Clinical trials were conducted according to different age groups

Article Snippet: BNT162b2 (Omi XBB.1.5) + RIV , COVID-19 and influenza , 2024-01-31 , Phase II , Active, not recruiting , Pfizer , NCT06237049.

Techniques: Clinical Proteomics

Ongoing and completed clinical trials of mRNA vaccines for the treatment of immunosuppressant patients/patients with autoimmune diseases

Journal: Signal Transduction and Targeted Therapy

Article Title: Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

doi: 10.1038/s41392-024-02002-z

Figure Lengend Snippet: Ongoing and completed clinical trials of mRNA vaccines for the treatment of immunosuppressant patients/patients with autoimmune diseases

Article Snippet: BNT162b2 (Omi XBB.1.5) + RIV , COVID-19 and influenza , 2024-01-31 , Phase II , Active, not recruiting , Pfizer , NCT06237049.

Techniques: Clinical Proteomics, Vaccines, Tandem Mass Spectroscopy

Concurrently administered vaccines

Journal: Signal Transduction and Targeted Therapy

Article Title: Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

doi: 10.1038/s41392-024-02002-z

Figure Lengend Snippet: Concurrently administered vaccines

Article Snippet: BNT162b2 (Omi XBB.1.5) + RIV , COVID-19 and influenza , 2024-01-31 , Phase II , Active, not recruiting , Pfizer , NCT06237049.

Techniques: Infection